<DOC>
	<DOCNO>NCT01333384</DOCNO>
	<brief_summary>The purpose study evaluate 24 month prospective follow - everyday clinical practice - resource utilization effectiveness treatment acromegalic patient Poland Somatuline Autogel 120 mg include extend injection interval .</brief_summary>
	<brief_title>Study Polish Acromegalic Patients Treated With Somatuline Autogel</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<criteria>Adult patient acromegaly treat least three injection Somatuline Autogel 120 mg Subjects must treat acromegaly least 1 year , medical treatment prior inclusion . One year historical data must available Active participation interventional noninterventional acromegaly clinical study . Previous participation observational / postmarketing study somatostatin analogue exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>